Epidemiology and pathology of HPV disease in males

Gynecologic Oncology

Volumn 117, Issue 2 SUPPL., 2010, Pages

  Giuliano, Anna R ^a   Anic, Gabriella ^a   Nyitray, Alan G ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Anal cancer; Genital warts; Head and neck cancer; HPV infection; Male; Natural history; Penile cancer; Recurrent respiratory papillomatosis; Transmission dynamics

Indexed keywords

WART VIRUS VACCINE;

ANAL CANAL; ANUS CANCER; AWARENESS; CIRCUMCISION; CONDYLOMA ACUMINATUM; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; DRUG SAFETY; HEAD AND NECK CANCER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; INCIDENCE; LARYNX PAPILLOMATOSIS; MALE GENITAL TRACT CANCER; PATHOPHYSIOLOGY; PENIS CANCER; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL TRANSMISSION; SEXUALITY; VACCINATION; VIRUS DETECTION;

ADOLESCENT; ADULT; AGED; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 77949774261     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.01.026     Document Type: Review

References (70)

1. Muñoz N., Castellsagué X., Bosch F.X., Tafur L., de Sanjosé S., Aristizabal N., et al. Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease. J. Natl. Cancer Inst. 88 (1996) 1068-1075
2. Castellsagué X., Ghaffari A., Daniel R.W., Bosch F.X., Muñoz N., and Shah K.V. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J. Infect Dis. 176 (1997) 353-361
3. Castellsagué X., Bosch F.X., Muñoz N., Meijer C.J., Shah K.V., de Sanjose S., et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N. Engl. J. Med. 346 (2002) 1105-1112
4. Watson M., Saraiya M., Ahmed F., Cardinez C.J., Reichman M.E., Weir H.K., et al. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods. Cancer 113 10 Suppl. (2008) 2841-2854
5. Human papillomaviruses. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monogr. Eval. Carcinog. Risks Hum. 90 (2007) 1-636
6. A. Giuliano, J. Palefsky, The efficacy of quadrivalent HPV (types 6/11/16/18) vaccine in reducing the incidence of HPV-related genital disease in young men. 2008 Conference of the European Research Organization on Genital Infection and Neoplasia (EUROGIN); 2008 Nov 12-15; Nice, France. Abstract SS 19-7a.
7. A.R. Giuliano, J.H. Lee, W.J. Fulp, L.L. Villa, E. Lazcano, M. Papenfuss, et al. International HPV incidence among men ages 18-70 years. Presented at the 25th International Papillomavirus Conference: Clinical & Educational Workshop; 2009 May 8-14; Malmö, Sweden. Abstract O-27.06.
8. Monk B.J., and Tewari K.S. The spectrum and clinical sequelae of human papillomavirus infection. Gynecol. Oncol. 107 2 Suppl, 1 (2007) S6-S13
9. Insinga R.P., Dasbach E.J., and Myers E.R. The health and economic burden of genital warts in a set of private health plans in the United States. Clin. Infect Dis. 36 (2003) 1397-1403
10. Dinh T.H., Sternberg M., Dunne E.F., and Markowitz L.E. Genital warts among 18- to 59-year-olds in the United States, national health and nutrition examination survey, 1999-2004. Sex Transm. Dis. 35 (2008) 357-360
11. Jeynes C., Chung M.C., and Challenor R. 'Shame on you'-the psychosocial impact of genital warts. Int. J. STD AIDS 20 (2009) 557-560
12. Lacey C.J. Therapy for genital human papillomavirus-related disease. J. Clin. Virol. 32 Suppl. 1 (2005) S82-S90
13. Wiley D.J., Douglas J., Beutner K., Cox T., Fife K., Moscicki A.B., et al. External genital warts: diagnosis, treatment, and prevention. Clin. Infect. Dis. 35 Suppl. 2 (2002) S210-224
14. Lacey C.J., Lowndes C.M., and Shah K.V. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 24 Suppl. 3 (2006) S3/35-41
15. Chan P.K., Luk A.C., Luk T.N., Lee K.F., Cheung J.L., Ho K.M., et al. Distribution of human papillomavirus types in anogenital warts of men. J. Clin. Virol. 44 (2009) 111-114
16. Derkay C.S. Task force on recurrent respiratory papillomas. A preliminary report. Arch. Otolaryngol. Head Neck Surg. 121 (1995) 1386-1391
17. Goon P., Sonnex C., Jani P., Stanley M., and Sudhoff H. Recurrent respiratory papillomatosis: an overview of current thinking and treatment. Eur. Arch. Otorhinolaryngol. 265 (2008) 147-151
18. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 9 Regs Limited-Use, Nov 2006 Sub (1973-2004)-Linked To County Attributes-Total U.S., 1969-2004 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission. 2007.
19. Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute; 2007. Available from: http://seer.cancer.gov/csr/1975_2004 [based on November 2006 SEER data submission, posted to the SEER website, 2007].
20. Frisch M., and Melbye M. Anal cancer. In: Schottenfeld D., and Fraumeni Jr. J. (Eds). Cancer epidemiology and prevention (2006), Oxford University Press, New York 830-840
21. Frisch M., Melbye M., and Moller H. Trends in incidence of anal cancer in Denmark. BMJ 306 (1993) 419-422
22. Parkin D.M., and Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 24 Suppl 3 (2006) S3/11-25
23. Chiao E.Y., Krown S.E., Stier E.A., and Schrag D. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J. Acquir. Immune Defic. Syndr. 40 (2005) 451-455
24. Cress R.D., and Holly E.A. Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973-1999. Prev. Med. 36 (2003) 555-560
25. Frisch M., Biggar R.J., and Goedert J.J. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J. Natl. Cancer Inst. 92 (2000) 1500-1510
26. Melbye M., Rabkin C., Frisch M., and Biggar R.J. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am. J. Epidemiol. 139 (1994) 772-780
27. Frisch M., Glimelius B., van den Brule A.J., Wohlfahrt J., Meijer C.J., Walboomers J.M., et al. Sexually transmitted infection as a cause of anal cancer. N. Engl. J. Med. 337 (1997) 1350-1358
28. Daling J.R., Madeleine M.M., Johnson L.G., Schwartz S.M., Shera K.A., Wurscher M.A., et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101 (2004) 270-280
29. Daling J.R., Weiss N.S., Hislop T.G., Maden C., Coates R.J., Sherman K.J., et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N. Engl. J. Med. 317 (1987) 973-977
30. Holly E.A., Whittemore A.S., Aston D.A., Ahn D.K., Nickoloff B.J., and Kristiansen J.J. Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J. Natl. Cancer Inst. 81 (1989) 1726-1731
31. Daling J.R., Weiss N.S., Klopfenstein L.L., Cochran L.E., Chow W.H., and Daifuku R. Correlates of homosexual behavior and the incidence of anal cancer. JAMA 247 (1982) 1988-1990
32. Hernandez B.Y., Barnholtz-Sloan J., German R.R., Giuliano A., Goodman M.T., King J.B., et al. Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003. Cancer 113 10 Suppl. (2008) 2883-2891
33. Bosch F.X., and Cardis E. Cancer incidence correlations: genital, urinary and some tobacco-related cancers. Int. J. Cancer 46 (1990) 178-184
34. Bleeker M.C., Heideman D.A., Snijders P.J., Horenblas S., Dillner J., and Meijer C.J. Penile cancer: epidemiology, pathogenesis and prevention. World J. Urol. 27 (2009) 141-150
35. Madsen B.S., van den Brule A.J., Jensen H.L., Wohlfahrt J., and Frisch M. Risk factors for squamous cell carcinoma of the penis-population-based case-control study in Denmark. Cancer Epidemiol. Biomarkers Prev. 17 (2008) 2683-2691
36. Daling J.R., Madeleine M.M., Johnson L.G., Schwartz S.M., Shera K.A., Wurscher M.A., et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int. J. Cancer 116 (2005) 606-616
37. Tsen H.F., Morgenstern H., Mack T., and Peters R.K. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control 12 (2001) 267-277
38. Maden C., Sherman K.J., Beckmann A.M., Hislop T.G., Teh C.Z., Ashley R.L., et al. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J. Natl. Cancer Inst. 85 (1993) 19-24
39. Brinton L.A., Li J.Y., Rong S.D., Huang S., Xiao B.S., Shi B.G., et al. Risk factors for penile cancer: results from a case-control study in China. Int. J. Cancer 47 (1991) 504-509
40. Hellberg D., Valentin J., Eklund T., and Nilsson S. Penile cancer: is there an epidemiological role for smoking and sexual behaviour?. Br. Med. J. (Clin Res Ed) 295 (1987) 1306-1308
41. Miralles-Guri C., Bruni L., Cubilla A.L., Castellsagué X., Bosch F.X., and de Sanjose S. Human papillomavirus prevalence and type distribution in penile carcinoma. J. Clin. Pathol. 62 (2009) 870-878
42. Rubin M.A., Kleter B., Zhou M., Ayala G., Cubilla A.L., Quint W.G., et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am. J. Pathol. 159 (2001) 1211-1218
43. Chaturvedi A.K., Engels E.A., Anderson W.F., and Gillison M.L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J. Clin. Oncol. 26 (2008) 612-619
44. Kreimer A.R., Clifford G.M., Boyle P., and Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol. Biomarkers Prev 14 (2005) 467-475
45. D'Souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 356 (2007) 1944-1956
46. Dunne E.F., Nielson C.M., Stone K.M., Markowitz L.E., and Giuliano A.R. Prevalence of HPV infection among men: a systematic review of the literature. J. Infect. Dis. 194 (2006) 1044-1057
47. Giuliano A.R., Lazcano-Ponce E., Villa L.L., Flores R., Salmeron J., Lee J.H., et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol. Biomarkers Prev. 17 (2008) 2036-2043
48. Nielson C.M., Flores R., Harris R.B., Abrahamsen M., Papenfuss M.R., Dunne E.F., et al. Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 1107-1114
49. Giuliano A.R., Nielson C.M., Flores R., Dunne E.F., Abrahamsen M., Papenfuss M.R., et al. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J. Infect. Dis. 196 (2007) 1146-1152
50. Van Doornum G.J., Prins M., Juffermans L.H., Hooykaas C., van den Hoek J.A., Coutinho R.A., et al. Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourin Med. 70 (1994) 240-246
51. Giuliano A.R., Lu B., Nielson C.M., Flores R., Papenfuss M.R., Lee J.H., et al. Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J. Infect. Dis. 198 (2008) 827-835
52. Partridge J.M., Hughes J.P., Feng Q., Winer R.L., Weaver B.A., Xi L.F., et al. Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J. Infect. Dis. 196 (2007) 1128-1136
53. Giuliano A.R., Harris R., Sedjo R.L., Baldwin S., Roe D., Papenfuss M.R., et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women's Health Study. J. Infect. Dis. 186 (2002) 462-469
54. Lu B., Wu Y., Nielson C.M., Flores R., Abrahamsen M., Papenfuss M., et al. Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study. J. Infect. Dis. 199 (2009) 362-371
55. Van Doornum G.J., Prins M., Juffermans L.H., Hooykaas C., van den Hoek J.A., Coutinho R.A., et al. Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourin Med 70 (1994) 240-246
56. Chin-Hong P.V., Vittinghoff E., Cranston R.D., Buchbinder S., Cohen D., Colfax G., et al. Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J. Infect. Dis. 190 (2004) 2070-2076
57. Vajdic C.M., van Leeuwen M.T., Jin F., Prestage G., Medley G., Hillman R.J., et al. Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men. Sex Transm. Infect. 85 (2009) 330-335
58. Nyitray A., Nielson C.M., Harris R.B., Flores R., Abrahamsen M., Dunne E.F., et al. Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men. J. Infect. Dis. 197 (2008) 1676-1684
59. Dunne E.F., Nielson C.M., Stone K.M., Markowitz L.E., and Giuliano A.R. Prevalence of HPV infection among men: a systematic review of the literature. J. Infect. Dis 194 (2006) 1044-1057
60. Kyo S., Inoue M., Koyama M., Fujita M., Tanizawa O., and Hakura A. Detection of high-risk human papillomavirus in the cervix and semen of sex partners. J. Infect. Dis. 170 (1994) 682-685
61. Campion M.J., Singer A., Clarkson P.K., and McCance D.J. Increased risk of cervical neoplasia in consorts of men with penile condylomata acuminata. Lancet 1 (1985) 943-946
62. Nielson C.M., Harris R.B., Dunne E.F., Abrahamsen M., Papenfuss M.R., Flores R., et al. Risk factors for anogenital human papillomavirus infection in men. J. Infect. Dis. 196 (2007) 1137-1145
63. Giuliano A.R., Lazcano E., Villa L.L., Flores R., Salmeron J., Lee J.H., et al. Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study. Int. J. Cancer 124 (2009) 1251-1257
64. Nielson C.M., Schiaffino M.K., Dunne E.F., Salemi J.L., and Giuliano A.R. Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners. J. Infect. Dis 199 (2009) 7-13
65. A.R. Giuliano, J.M. Palefsky, S. Goldstone, E.D. Moreira, M.E. Penny, C. Aranda, et al., The efficacy of quadrivalent HPV vaccine in preventing HPV 6/11/16/18-related external genital disease and anogenital infection in young men. N. Engl. J. Med. (Under Review).
66. Fairley C.K., Hocking J.S., Gurrin L.C., Chen M.Y., Donovan B., and Bradshaw C. Rapid decline in presentations for genital warts after the implementation of a national quadrivalent human papillomavirus vaccination program for young women. Sex Transm. Infect 85 (2009) 499-502
67. Nielsen A., Munk C., Liaw K.L., and Kjaer S.K. Awareness of human papillomavirus in 23 000 Danish men from the general male population. Eur. J. Cancer Prev 18 (2009) 236-239
68. Nielsen A, Munk C, Liaw K, Nøhr B, KJær S. Awareness of human papillomavirus in Denmark. Presented at the 25th International Papillomavirus Conference: Clinical & Educational Workshop; 2009 May 8-14; Malmö, Sweden. Abstract P-22.11.
69. th International Papillomavirus Conference: Clinical & Educational Workshop; 2009 May 8-14; Malmö, Sweden. Abstract O-27.02.
70. Kjaer S.K., Tran T.N., Sparen P., Tryggvadottir L., Munk C., Dasbach E., et al. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J. Infect. Dis. 196 (2007) 1447-1454